Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2017-10-26
2018-11-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Changes in Perception and Cognition During a Meditation Retreat
NCT04449913
Efficacy of Hypnosis on Pain and Anxiety During Lumbar Puncture for Etiological Diagnosis of Cognitive Impairment
NCT04368572
Imaging Cerebral and Sub-cerebral Correlates of Meditative States
NCT01262404
Brain and Mindfulness
NCT03117478
Investigation of Mnesic Capacities in Patients With a Disorder of Consciousness
NCT06959212
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.
"control", "meditation", "hypnosis".
three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.
Group 2
three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.
"control", "meditation", "hypnosis".
three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"control", "meditation", "hypnosis".
three instructions will be given to each participant: "control", "meditation", "hypnosis". The order of "meditation" and "hypnosis" will be randomized amongst two groups to avoid order effects.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index between 18.5 and 30
* Covered by health insurance
* motivated to participate
* signed informed consent
* normal or corrected-to-normal eyesight
* sufficient command of French to be able to follow the instructions
Exclusion Criteria
* chronic pain or another medical condition altering pain perception
* use of medication that affects the central nervous system
* use of opioids or antidepressant medication
* severe auditory loss
* consumption of alcohol or intoxicants on the day of the experiments and the day preceding the experiments
* pregnancy, breastfeeding or having given birth \<6months ago
* any contra-indication to Magnetic Resonance Imaging (metal implants or foreign bodies), agitation, claustrophobia
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antoine LUTZ, PhD
Role: PRINCIPAL_INVESTIGATOR
Lyon Neuroscience Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon Hôpital le Vinatier/Inserm
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lutz A. Regulation of attention and emotions by meditation: neurophysiological basis and implications for mental and physical health. In: 12th BIAL Foundation Symposium "Amplified states of consciousness"; 2018 Apr 6; Porto, Portugal. Lutz A. Méditation, hypnose… se soigner par la conscience. In: INSERM - Culture scientifique (webinar); 2022 Dec 13; Paris, France (online). Lutz A. Mindfulness meditation from the lenses of phenomenology and neurosciences. In: USC Center for Mindful Science - Invited lecture; 2022 Dec 12; Los Angeles (CA), USA. Lutz A. Neurophenomenology after Varela (1996). In: Metanoia/Ouroboros - Seminar; 2021 Sep 1; (online).
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01923-50
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL17_0274
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.